Honz Pharmaceutical Co., Ltd.

隶属于 hainan hongshi investment co., ltd.

The company is a listed enterprise focusing on children's health. It is a national high-tech enterprise, and has pioneered the establishment of an enterprise postdoctoral research workstation with children's medicine as the main research direction. The company adheres to the corporate tenet of “good medicine, bless humanity”, actively implements the “Children's Health Strategy” and “Quality Strategy”, and ingeniously builds a national brand in the children's health industry. The company is a leading domestic children's health enterprise whose main business is the R&D, production and sales of children's medicines, maternal and child health products, and medical devices such as medical protective equipment. Main products: Respiratory medicine, digestive medicine, anti-allergic drugs, antibiotics, nutritional supplements, antibacterial and antiviral drugs, antipyretic and analgesic drugs, gynecological drugs, masks, etc. Corporate honors: Top 500 Asian Brands, the 8th Hainan Excellent Enterprise, etc. Won the honorary certificate of “Guangdong High-tech Product”, the title of “Top 100 Pharmaceutical Digital Brands”, “2022 Growth Potential Star” Company, “Leading Force - High-Quality Pharmaceutical Development Achievement Enterprise in China”, the 2023 Hainan Top 40 Manufacturing Enterprises List, the “Health Industry's Most Growing Listed Company” Award, the 2023 “Excellent ESG Case of Hainan Listed Companies”, the “2023 Haikou 'Trade Union Cup' Pharmaceutical Industry Worker Labor Skills Competition - Second Prize in the Chemical Inspection and Operation Skills Competition”, and “Guangdong Provincial Enterprise Technology Honors such as “Center” and “Famous Brand Product of Guangdong Province”.